Philips-led PreciseOnco Consortium Receives EUR 14.9 Million IHI Grant to Advance Precision Cancer Treatment

Tuesday, Feb 3, 2026 4:01 am ET1min read
PHG--

The PreciseOnco research consortium, coordinated by Philips, has been awarded a EUR 14.9 million grant from the EU's Innovative Health Initiative (IHI) to drive breakthroughs in precision cancer treatment. The five-year program aims to standardize and enhance minimally invasive cancer treatments through advanced medical imaging, robotic guidance technologies, and AI. The consortium includes industry partners, research organizations, medical societies, and leading European hospitals.

Philips-led PreciseOnco Consortium Receives EUR 14.9 Million IHI Grant to Advance Precision Cancer Treatment

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet